Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Angiodynamics (ANGO) over the last 17 years, with Q1 2025 value amounting to $0.03.

  • Angiodynamics' Debt to Equity fell 3807.27% to $0.03 in Q1 2025 from the same period last year, while for Feb 2025 it was $0.03, marking a year-over-year decrease of 3807.27%. This contributed to the annual value of $0.02 for FY2024, which is 8652.82% down from last year.
  • Angiodynamics' Debt to Equity amounted to $0.03 in Q1 2025, which was down 3807.27% from $0.03 recorded in Q4 2024.
  • Over the past 5 years, Angiodynamics' Debt to Equity peaked at $0.17 during Q2 2023, and registered a low of $0.01 during Q3 2023.
  • Its 5-year average for Debt to Equity is $0.07, with a median of $0.06 in 2021.
  • As far as peak fluctuations go, Angiodynamics' Debt to Equity surged by 16432.54% in 2021, and later plummeted by 9220.16% in 2023.
  • Quarter analysis of 5 years shows Angiodynamics' Debt to Equity stood at $0.06 in 2021, then skyrocketed by 152.48% to $0.15 in 2022, then plummeted by 83.97% to $0.02 in 2023, then increased by 13.51% to $0.03 in 2024, then increased by 1.29% to $0.03 in 2025.
  • Its Debt to Equity was $0.03 in Q1 2025, compared to $0.03 in Q4 2024 and $0.02 in Q3 2024.